Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan
Authors:
- 10 March 2010
- journal article
- research article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 64 (8) , 1095-1099
Abstract
To compare hypoglycaemic events, glycated haemoglobin (HbA1c) and changes in body weight in Muslim patients with Type 2 diabetes receiving Humalog Mix 50 and human Mixtard 30 twice daily during Ramadan fasting. Data were collected from Muslim patients with Type 2 diabetes attending primary care practices in North-West London, who were on Mixtard 30 insulin twice daily before Ramadan. Group 1 had their evening insulin changed to Humalog Mix 50 (n = 26) 2 weeks before Ramadan, i.e. taking Mixtard 30 at predawn meal and Humalog Mix 50 at the sunset meal during Ramadan. As the major proportion of the daily caloric intake was consumed at the sunset meal, the rationale of switching the evening dose from human Mixtard 30 to Humalog Mix 50 was to provide more rapid-acting insulin that has shorter time of onset and peak time for the large evening meal to improve the postprandial glucose control without increasing the risk of hypoglycaemia. Group 2 continued on Mixtard 30 twice daily (n = 26). All patients received structured education about how to identify and manage hypoglycaemia during Ramadan. Group 1 had a mean HbA1c reduction of 0.48% (p = 0.0001) before and after Ramadan, whereas group 2 had a mean HbA1c increase of 0.28% (p = 0.007). Group 1 was associated with a small reduction of 0.04 (p = 0.81) in the mean number of hypoglycaemic events during Ramadan compared with before Ramadan, whereas group 2 was associated with an increase of 0.15 (p = 0.43), although these differences between the groups were not statistically significant following adjustment for baseline factors [LSM difference between groups = 0.135, p = 0.36, 95% confidence limits (-0.16, 0.43)]. Changing to humalog Mix 50 during Ramadan resulted in improvement in glycaemic control without increasing the incidence of hypoglycaemia.Keywords
This publication has 14 references indexed in Scilit:
- Ramadan-focused education and awareness in type 2 diabetesDiabetologia, 2008
- Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in RamadanActa Diabetologica, 2008
- Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of RamadanClinical Therapeutics, 2008
- A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fastingDiabetes Research and Clinical Practice, 2007
- Premixed insulin treatment for type 2 diabetes: analogue or human?Diabetes, Obesity and Metabolism, 2006
- Diabetes and Ramadan: Review of the literatureDiabetes Research and Clinical Practice, 2006
- Recommendations for Management of Diabetes During RamadanDiabetes Care, 2005
- The Efficacy and Safety of Glimepiride in the Management of Type 2 Diabetes in Muslim Patients During RamadanDiabetes Care, 2005
- The Effects of Diet, Sulfonylurea, and Repaglinide Therapy on Clinical and Metabolic Parameters in Type 2 Diabetic Patients During RamadanEndocrine Research, 2004
- The fast of Ramadan.BMJ, 1992